maheshji how isyour old pick jubilant ind at cmp?

Mahesh,

I admire your enthusiasm for Syngene.

I have few questions though, would be great if you can answer them -

1) What is it that can go wrong for Syngene? I don't see anything negative listed in the thread and that kind of scares me.

2) In the entire thread, I only see financials being talked about (P/E, ROE, ROCE, Capex, EV etc.) but not enough discussion on what is company "actually" doing at the next level of detail. What are the name of the molecules? Who are their customers? Do we know which area the molecules are in (Dermatology? Paediatric? etc.)

Thanks,
Rupesh

P. S. Not invested

1. Are you looking for multibaggers (there are some, but not all) **Looking for a balanced portfolio- medium risk high return**
2. Are you looking for stable growth (viz. 4% above bank FD) **targeted annual growth of 20-30%**

Your risk return expectations seemed skewed. With the kind of diversity you're going for (15 stocks) you can't expect high returns. You have to severely reduce the number of stocks.

What you can do is have a bulk of your investments in few stocks you think will increase multiple times and a little bit on companies you're in lookout for.

Target price is a good way to have a balanced portfolio, to preserve capital - but the returns would be patchy. That is because you'll sell something when it doubles and then lo-and-behold it goes up 25 times.

Time horizon is different for each stock, I try to go by target price, if achieved allocate to other stronger ideas

You have to think it out clearly, maybe write it in a paper. Are you looking for balanced returns or high-returns.

By infra I meant stocks dependent upon Infra as a proxy, they would do well as macro improves

Then shouldn't they be in Real State sector?

Dear Ashishpatil80,

Earlier, promoters pledged their share to subscribe the share warrant issued to them and now they are pledging more shares to increase their holding in the company by way of purchasing more shares from open market. so, it is not true that they are not interested in their stock.

regards,